Table 1

Features of 22 reported postmortem FXTAS cases

Duration from onset (years)CCG repeatsMCP signAdditional neuropathological findings
WheelchairDeath
Greco et al3; 11 males6 610113
1380
NA580Y
131471PD
1219105
71377Y
5688Y
NA392
131688Y
4693Y
NA165
Tassone et al2; 8 femalesNANA70
1080NAD (B&B V-VI)
687
1475YMS
765AD (B&B V-VI)
47NAD (B&B V-VI)
4659NPD
878AD (B&B V-VI)
Louis et al; 1 male7 7990
Present series: De Pablo-Fernandez et al; 2 males131472YPD (Braak 5)
78100NPD (Braak 3)
Total: 8 females; 14 males89Y 64% (7/11)
  • AD, Alzheimer disease; B&B, Braak and Braak stage for Alzheimer; Braak, Braak stage for Parkinson's disease; FXTAS, fragile X-associated tremor/ataxia syndrome; MCP, middle cerebellar peduncle; MS, multiple sclerosis; N, no; NA, not applicable; PD, Parkinson's disease; Y, yes.